Biovision
Human CellExp™ Biotinylated PD-L1, Human Recombinant
- SKU:
- 26-P1422
- Availability:
- Usually Shipped in 5 Working Days
- Storage Temperature:
- -20ºC
- Shipping Conditions:
- Gel Pack
- Shelf Life:
- 12 months
Description
Biomolecule/Target: N/A
Synonyms: Programmed Cell Death 1 Ligand 1, PDL1, PDCD1L1, CD274, B7 homolog 1, B7H1, B7-H1
Alternates names: Programmed Cell Death 1 Ligand 1, PDL1, PDCD1L1, CD274, B7 homolog 1, B7H1, B7-H1
Taglines: N/A
Taglines: USA
Country of Animal Origin: USA
NCBI Gene ID #.: 29126
NCBI Gene Symbol: CD274
Gene Source: Human
Accession #: Q9NZQ7
Recombinant: False
Source: HEK293 cells
Purity by SDS-PAGE #: ≥95%
Assay: SDS-PAGE
Purity: N/A
Assay #2: N/A
Endotoxin Level: N/A
Activity (Specifications/test method): BioVision’s Biotinylated Human Recombinant PD-L1 has been tested for its biotin content (2-3 biotins per PD-L1 as determined by K811-100) and ability to bind Human PD-1 (Cat. No. 7498) in a functional ELISA with a linear range of 2-125 ng (0.02–1.25 μg/ml)
Biological activity: N/A
Results: N/A
Binding Capacity: BioVision’s Biotinylated Human Recombinant PD-L1 has been tested for its biotin content (2-3 biotins per PD-L1 as determined by K811-100) and ability to bind Human PD-1 (Cat. No. 7498) in a functional ELISA with a linear range of 2-125 ng (0.02–1.25 μg/ml)
Unit Definition: N/A
Molecular Weight: The protein is fused with 6×His tag at the N-terminus, has a calculated MW of 26.4 kDa. The protein migrates as 35 -40 kDa in SDS-PAGE under reducing conditions due to glycosylation.
Concentration: 0.5 mg/ml
Appearance: Sterile Filtered colorless solution
Physical form description: Liquid
Reconstitution Instructions: N/A
Background Information: Human Programmed Cell Death 1 Ligand-1 (PD-L1) is also known as CD274 and B7-H1) is a type I transmembrane protein which binds to its receptor, Programmed Cell Death protein 1 (PD-1). PD-L1 is widely distributed on leukocytes, nonhematopoietic cells, and in nonlymphoid tissues including islets. PD-L1 and PD-1 pathway serves as an “immune checkpoint” and its blockade is a highly promising therapy for a broad spectrum of cancers.
Amino acid sequence: Leu 25-Gln 167
Handling: Centrifuge the vial prior to opening.
Usage: N/A